# Third Line Highly Active Antiretroviral Therapy (HAART) in HIV-infected Children

> **NCT01225406** · — · COMPLETED · sponsor: **The HIV Netherlands Australia Thailand Research Collaboration** · enrollment: 56 (actual)

## Conditions studied

- This Study is Designed to Collect Treatment Data of Thai Children on Third Line ARV Therapy

## Interventions

- **DRUG:** Tenofovir

## Key facts

- **NCT ID:** NCT01225406
- **Lead sponsor:** The HIV Netherlands Australia Thailand Research Collaboration
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2013-08
- **Final completion:** 2013-12
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2020-07-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01225406

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01225406, "Third Line Highly Active Antiretroviral Therapy (HAART) in HIV-infected Children". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01225406. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*